Schedule 13G ownership disclosure

BOUNDLESS BIO INC

Common stock, par value $0.0001 per share (the "Shares") · CUSIP: 10170A100

Event date: 2025-11-26

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Citadel Advisors LLC

    Shares: 830,936.00 · Class: 3.7%

  • Citadel Advisors Holdings LP

    Shares: 830,936.00 · Class: 3.7%

  • Citadel GP LLC

    Shares: 830,936.00 · Class: 3.7%

  • Citadel Securities LLC

    Shares: 602,452.00 · Class: 2.7%

  • Citadel Securities Group LP

    Shares: 602,452.00 · Class: 2.7%

  • Citadel Securities GP LLC

    Shares: 602,452.00 · Class: 2.7%

  • Kenneth Griffin

    Shares: 1,433,388.00 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-118546
Form type
SCHEDULE 13G
Filer
Boundless Bio, Inc.
CIK
CIK 1782303
Filed
Dec 04, 2025
Reporting period
Nov 26, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub